LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Dasatinib
1.7783
8.98 17.25 1 445 0.0022 -0.4552
MN20160310_N02
F13
MCF 10A-H2B-mCherry Dasatinib
1.7783
8.98 17.25 545 445 1.2245 1.0883
MN20160310_N02
F13
MCF 10A-H2B-mCherry Dasatinib
1.7783
8.98 17.25 1 445 0.0022 -0.4552
MN20160310_N02
L16
MCF 10A-H2B-mCherry Dasatinib
1.7783
8.98 17.25 930 445 2.0896 1.3404
MN20160310_N02
L16
MCF 10A-H2B-mCherry Dasatinib
1.7783
10.95 17.25 1 471 0.0021 -0.4494
MN20160310_N02
F13
MCF 10A-H2B-mCherry Dasatinib
1.7783
10.95 17.25 641 471 1.3593 1.1329
MN20160310_N02
F13
MCF 10A-H2B-mCherry Dasatinib
1.7783
10.95 17.25 1 471 0.0021 -0.4494
MN20160310_N02
L16
MCF 10A-H2B-mCherry Dasatinib
1.7783
10.95 17.25 940 471 1.9933 1.3110
MN20160310_N02
L16
MCF 10A-H2B-mCherry Dasatinib
1.7783
12.91 17.25 1 494 0.0020 -0.4446
MN20160310_N02
F13
MCF 10A-H2B-mCherry Dasatinib
1.7783
12.91 17.25 737 494 1.4893 1.1715
MN20160310_N02
F13
MCF 10A-H2B-mCherry Dasatinib
1.7783
12.91 17.25 1 494 0.0020 -0.4446
MN20160310_N02
L16
MCF 10A-H2B-mCherry Dasatinib
1.7783
12.91 17.25 952 494 1.9238 1.2894
MN20160310_N02
L16
MCF 10A-H2B-mCherry Dasatinib
1.7783
14.88 17.25 1 534 0.0019 -0.4373
MN20160310_N02
F13
MCF 10A-H2B-mCherry Dasatinib
1.7783
14.88 17.25 793 534 1.4838 1.1659
MN20160310_N02
F13
MCF 10A-H2B-mCherry Dasatinib
1.7783
14.88 17.25 1 534 0.0019 -0.4373
MN20160310_N02
L16
MCF 10A-H2B-mCherry Dasatinib
1.7783
14.88 17.25 979 534 1.8319 1.2600
MN20160310_N02
L16
MCF 10A-H2B-mCherry Dasatinib
1.7783
16.85 17.25 1 655 0.0015 -0.4188
MN20160310_N02
F13
MCF 10A-H2B-mCherry Dasatinib
1.7783
16.85 17.25 812 655 1.2386 1.0832
MN20160310_N02
F13
MCF 10A-H2B-mCherry Dasatinib
1.7783
16.85 17.25 1 655 0.0015 -0.4188
MN20160310_N02
L16
MCF 10A-H2B-mCherry Dasatinib
1.7783
16.85 17.25 1016 655 1.5498 1.1741
MN20160310_N02
L16
MCF 10A-H2B-mCherry Dasatinib
1.7783
18.82 17.25 1 800 0.0012 -0.4022
MN20160310_N02
F13
MCF 10A-H2B-mCherry Dasatinib
1.7783
18.82 17.25 859 800 1.0731 1.0256
MN20160310_N02
F13
MCF 10A-H2B-mCherry Dasatinib
1.7783
18.82 17.25 1 800 0.0012 -0.4022
MN20160310_N02
L16
MCF 10A-H2B-mCherry Dasatinib
1.7783
18.82 17.25 1034 800 1.2917 1.0946
MN20160310_N02
L16
MCF 10A-H2B-mCherry Dasatinib
1.7783
20.79 17.25 1 1001 0.0010 -0.3849
MN20160310_N02
F13